Argos Therapeutics, Inc. (NASDAQ: ARGS) Employee Directory

Biotechnology ResearchNorth Carolina, United States51-200 Employees

Argos Therapeutics is an immuno-oncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis® technology platform. Argos'​ most advanced product candidate, rocapuldencel-T, is being evaluated in the pivotal ADAPT Phase 3 clinical trial for the treatment of metastatic renal cell carcinoma (mRCC). In addition, rocapuldencel-T is being studied in Phase 2 investigator-initiated clinical trials as neoadjuvant therapy for renal cell carcinoma (RCC) and for the treatment of non-small cell lung cancer (NSCLC). Argos is also developing a separate Arcelis®-based product candidate, AGS-004, for the treatment of human immunodeficiency virus (HIV), which is currently being evaluated in an investigator-initiated Phase 2 clinical trial aimed at HIV eradication in adult patients.

Find Argos Therapeutics, Inc. (NASDAQ: ARGS) employees' phone numbers or email addresses

Argos Therapeutics, Inc. (NASDAQ: ARGS) Global Highlights

Location
Employees

North America
24

Minus sign iconPlus sign icon
  • United States Of America
    23
  • Mexico
    1

Europe
4

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    2
  • Ireland
    1
  • France
    1

Asia
2

Minus sign iconPlus sign icon
  • Afghanistan
    1
  • India
    1

South America
1

Minus sign iconPlus sign icon
  • Argentina
    1

Argos Therapeutics, Inc. (NASDAQ: ARGS)'s Leadership

  • Stylized image of a person
    J. A.
    President
    Phone icon
  • Stylized image of a person
    K. G.
    Associate Director Quality Assurance
    Phone icon
  • Stylized image of a person
    G. S.
    Quality Assurance Manager
    Phone icon
  • Stylized image of a person
    R. S.
    Senior Calibration Engineer
    Phone icon
  • Stylized image of a person
    G. P.
    Senior Scientist
    Phone icon
  • Stylized image of a person
    J. M.
    Executive/Administrative Assistant
    Phone icon
  • Stylized image of a person
    L. B.
    Executive Assistant
    Phone icon
  • Stylized image of a person
    J. A.
    Ventas
    Phone icon

Contact profiles from Argos Therapeutics, Inc. (NASDAQ: ARGS)

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    B. D.
    IT Support
    Phone icon
    United StatesNorth Carolina
    Oct 22, 2024
  • Stylized image of a person
    E. P. H.
    Finance Associate
    Phone icon
    United StatesNorth Carolina
  • Stylized image of a person
    J. W.
    Assay Development Associate
    Phone icon
    United StatesNorth Carolina
    Mar 24, 2025
  • Stylized image of a person
    P. H.
    Accounting Associate
    Phone icon
    United StatesNorth Carolina
    Oct 16, 2024
  • Stylized image of a person
    T. C.
    School Counselor
    Phone icon
    United StatesVirginia
    Jul 16, 2025
  • Stylized image of a person
    J. P. Z.
    Ventas
    Phone icon
    Argentina
    Oct 20, 2025
  • Stylized image of a person
    T. P.
    Teacher
    Phone icon
    IndiaKerala
    Jul 18, 2025
  • Stylized image of a person
    R. B.
    Phone icon
    UNITED STATES
    Apr 25, 2023
  • Stylized image of a person
    W. J.
    Phone icon
    UNITED STATES
    Mar 07, 2023
  • Stylized image of a person
    E. R.
    Supervisor And Turp
    Phone icon
    Afghanistan
    Sep 11, 2025

Frequently Asked Questions

What is Argos Therapeutics, Inc. (NASDAQ: ARGS) known for?

Minus sign iconPlus sign icon
Argos Therapeutics, Inc. (NASDAQ: ARGS) was founded in 1997 operates in the Biotechnology Research industry. The company's main headquarters is located in 4233 Technology Drive Durham, North Carolina 27704 US; you can contact the main corporate office by phone at . Explore Argos Therapeutics, Inc. (NASDAQ: ARGS)'s company overview page for more information.

What is Argos Therapeutics, Inc. (NASDAQ: ARGS)'s most common email format?

Minus sign iconPlus sign icon
Argos Therapeutics, Inc. (NASDAQ: ARGS) employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Argos Therapeutics, Inc. (NASDAQ: ARGS) email formats with LeadIQ.

How many employees does Argos Therapeutics, Inc. (NASDAQ: ARGS) have currently?

Minus sign iconPlus sign icon
Argos Therapeutics, Inc. (NASDAQ: ARGS) has approximately 61 employees as of October 2025. These team members are located across 4 continents, including North AmericaEuropeAsia.

Who are Argos Therapeutics, Inc. (NASDAQ: ARGS)'s key employees and leadership?

Minus sign iconPlus sign icon

As of October 2025, Argos Therapeutics, Inc. (NASDAQ: ARGS)'s key employees include:

  • President: J. A.
  • Associate Director Quality Assurance: K. G.
  • Quality Assurance Manager: G. S.
  • Senior Calibration Engineer: R. S.
  • Senior Scientist: G. P.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.